According to the Dian Diagnosis announcement, Chen Haibin, the controlling shareholder of the company, renewed the pledge of 16 million shares of the company, accounting for 9.73% of its shares and 2.56% of the company's total share capital. The pledge was China Merchants Securities Co., Ltd., and the purpose of the pledge was to repay the previous pledged loan. The pledge period was from August 18, 2026 to August 18, 2027. This pledge is a renewal of the previous pledge and does not involve additional financing. As of the disclosure date of the announcement, Chen Haibin and his co-actors pledged a total of 61.8 million shares, accounting for 35.30% of their shares and 9.89% of the company's total share capital. There is no risk of liquidation or forced transfer, which will not lead to a change in the company's actual control.

According to the Dian Diagnosis announcement, Chen Haibin, the controlling shareholder of the company, renewed the pledge of 16 million shares of the company, accounting for 9.73% of its shares and 2.56% of the company's total share capital. The pledge was China Merchants Securities Co., Ltd., and the purpose of the pledge was to repay the previous pledged loan. The pledge period was from August 18, 2026 to August 18, 2027. This pledge is a renewal of the previous pledge and does not involve additional financing. As of the disclosure date of the announcement, Chen Haibin and his co-actors pledged a total of 61.8 million shares, accounting for 35.30% of their shares and 9.89% of the company's total share capital. There is no risk of liquidation or forced transfer, which will not lead to a change in the company's actual control.